Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 8 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HBE0
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0008270 | zinc ion binding | 6 | 1 |
GO:0043167 | ion binding | 2 | 1 |
GO:0043169 | cation binding | 3 | 1 |
GO:0046872 | metal ion binding | 4 | 1 |
GO:0046914 | transition metal ion binding | 5 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 22 | 24 | PF00082 | 0.472 |
CLV_PCSK_PC1ET2_1 | 22 | 24 | PF00082 | 0.472 |
CLV_PCSK_SKI1_1 | 107 | 111 | PF00082 | 0.623 |
CLV_PCSK_SKI1_1 | 81 | 85 | PF00082 | 0.620 |
CLV_PCSK_SKI1_1 | 92 | 96 | PF00082 | 0.535 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.594 |
DEG_SPOP_SBC_1 | 42 | 46 | PF00917 | 0.358 |
DOC_CYCLIN_RxL_1 | 78 | 87 | PF00134 | 0.441 |
DOC_PP1_RVXF_1 | 68 | 75 | PF00149 | 0.687 |
DOC_PP4_FxxP_1 | 35 | 38 | PF00568 | 0.441 |
DOC_USP7_MATH_1 | 134 | 138 | PF00917 | 0.721 |
DOC_USP7_MATH_1 | 47 | 51 | PF00917 | 0.463 |
DOC_USP7_UBL2_3 | 5 | 9 | PF12436 | 0.637 |
DOC_WW_Pin1_4 | 130 | 135 | PF00397 | 0.607 |
LIG_BRCT_BRCA1_1 | 70 | 74 | PF00533 | 0.722 |
LIG_deltaCOP1_diTrp_1 | 31 | 35 | PF00928 | 0.372 |
LIG_FHA_1 | 52 | 58 | PF00498 | 0.336 |
LIG_FHA_1 | 94 | 100 | PF00498 | 0.616 |
LIG_FHA_2 | 77 | 83 | PF00498 | 0.571 |
LIG_LIR_Apic_2 | 34 | 38 | PF02991 | 0.402 |
LIG_SH2_CRK | 11 | 15 | PF00017 | 0.570 |
LIG_SH2_STAP1 | 16 | 20 | PF00017 | 0.354 |
LIG_SH3_3 | 72 | 78 | PF00018 | 0.573 |
MOD_CK1_1 | 43 | 49 | PF00069 | 0.388 |
MOD_CK2_1 | 25 | 31 | PF00069 | 0.363 |
MOD_CK2_1 | 76 | 82 | PF00069 | 0.555 |
MOD_GlcNHglycan | 112 | 115 | PF01048 | 0.687 |
MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.701 |
MOD_GlcNHglycan | 45 | 48 | PF01048 | 0.418 |
MOD_GlcNHglycan | 49 | 52 | PF01048 | 0.425 |
MOD_GSK3_1 | 123 | 130 | PF00069 | 0.702 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.359 |
MOD_GSK3_1 | 51 | 58 | PF00069 | 0.258 |
MOD_N-GLC_1 | 18 | 23 | PF02516 | 0.472 |
MOD_NEK2_1 | 57 | 62 | PF00069 | 0.239 |
MOD_NEK2_2 | 51 | 56 | PF00069 | 0.472 |
MOD_PIKK_1 | 57 | 63 | PF00454 | 0.329 |
MOD_PK_1 | 68 | 74 | PF00069 | 0.485 |
MOD_PK_1 | 9 | 15 | PF00069 | 0.626 |
MOD_Plk_2-3 | 31 | 37 | PF00069 | 0.344 |
MOD_ProDKin_1 | 130 | 136 | PF00069 | 0.609 |
MOD_SUMO_for_1 | 103 | 106 | PF00179 | 0.599 |
MOD_SUMO_for_1 | 140 | 143 | PF00179 | 0.575 |
MOD_SUMO_rev_2 | 82 | 91 | PF00179 | 0.567 |
MOD_SUMO_rev_2 | 98 | 105 | PF00179 | 0.682 |
TRG_DiLeu_BaLyEn_6 | 120 | 125 | PF01217 | 0.537 |
TRG_Pf-PMV_PEXEL_1 | 81 | 85 | PF00026 | 0.644 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P713 | Leptomonas seymouri | 61% | 97% |
A0A0S4KLW4 | Bodo saltans | 35% | 100% |
A0A1X0PAA9 | Trypanosomatidae | 45% | 100% |
A0A3Q8IHW3 | Leishmania donovani | 77% | 100% |
A0A3S5IRZ4 | Trypanosoma rangeli | 54% | 81% |
A4IAI8 | Leishmania infantum | 78% | 100% |
C9ZLQ0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 100% |
Q4Q2C4 | Leishmania major | 76% | 100% |